Hamed Shahbazi

Mr. Hamed Shahbazi is an Independent Director at The Metals Royalty Co., Inc., a Chairman at HealWELL AI, Inc., an Independent Non-Executive Director at Niagen Bioscience, Inc., a President & Director at CRH Medical Corp., a Lead Independent Director at BBTV Holdings, Inc., a Chief Executive Officer at Well Health Acquisition Corp., a Chairman & Chief Executive Officer at WELL Health Technologies Corp., a Chairman at WELLSTAR Technologies Corp., a President at Impactreneur Capital Corp.
and a Venture Partner at Pender Private Equity Fund Management, Inc. He is on the Board of Directors at The Metals Royalty Co., Inc., Niagen Bioscience, Inc., CRH Medical Corp., BBTV Holdings, Inc. and 15384150 Canada, Inc. Mr. Shahbazi was previously employed as an Independent Director by Risetech Capital Corp., an Independent Director by Danacore Industries, Inc., an Independent Director by Hire Technologies, Inc., an Independent Director by Aequus Pharmaceuticals, Inc., an Independent Director by Oyster Oil & Gas Ltd., a Chairman & Chief Executive Officer by TIO Networks Corp., and an Advisor by Core Innovation Capital.
He also served on the board at Tantalus Systems Holding, Inc., Movarie Capital Ltd., Blue Gold Mining, Inc., Bay Talent Group, Inc. /Old/ and BroadbandTV Corp.
He received his undergraduate degree from the University of British Columbia.